DOCSLIB.ORG
  • Sign Up
  • Log In
  • Upload
  • Sign Up
  • Log In
  • Upload
  • Home
  • »  Tags
  • »  Molsidomine

Molsidomine

  • 2013 ESC Guidelines on the Management of Stable Coronary

    2013 ESC Guidelines on the Management of Stable Coronary

  • 심한 이형 협심증 환자에서 경구 Nitric Oxide Donor(Molsidomine) 효과

    심한 이형 협심증 환자에서 경구 Nitric Oxide Donor(Molsidomine) 효과

  • NITROGYLCERIN and ETHYLENE GLYCOL DINITRATE Criteria for a Recommended Standard OCCUPATIONAL EXPOSURE to NITROGLYCERIN and ETHYLENE GLYCOL DINITRATE

    NITROGYLCERIN and ETHYLENE GLYCOL DINITRATE Criteria for a Recommended Standard OCCUPATIONAL EXPOSURE to NITROGLYCERIN and ETHYLENE GLYCOL DINITRATE

  • Treatment of Children with Pulmonary Hypertension. Expert Consensus Statement on the Diagnosis and Treatment of Paediatric Pulmonary Hypertension

    Treatment of Children with Pulmonary Hypertension. Expert Consensus Statement on the Diagnosis and Treatment of Paediatric Pulmonary Hypertension

  • Cardiovascular Implications in the Use of PDE5 Inhibitor Therapy

    Cardiovascular Implications in the Use of PDE5 Inhibitor Therapy

  • NCX-4040, a Unique Nitric Oxide Donor, Induces Reversal of Drug-Resistance in Both ABCB1- and ABCG2-Expressing Multidrug Human Cancer Cells

    NCX-4040, a Unique Nitric Oxide Donor, Induces Reversal of Drug-Resistance in Both ABCB1- and ABCG2-Expressing Multidrug Human Cancer Cells

  • Molsidomine, Nicorandil, Trimetazidine의 안전성 관련 체계적 고찰

    Molsidomine, Nicorandil, Trimetazidine의 안전성 관련 체계적 고찰

  • United States Patent (19) 11 Patent Number: 6,037,346 Doherty, Jr

    United States Patent (19) 11 Patent Number: 6,037,346 Doherty, Jr

  • EUROPEAN PHARMACOPOEIA 10.0 Index 1. General Notices

    EUROPEAN PHARMACOPOEIA 10.0 Index 1. General Notices

  • A Study of Vericiguat in Participants with Heart Failure with Reduced Ejection Fraction (Hfref) (MK-1242-001) (VICTORIA)

    A Study of Vericiguat in Participants with Heart Failure with Reduced Ejection Fraction (Hfref) (MK-1242-001) (VICTORIA)

  • Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

    Federal Register / Vol. 60, No. 80 / Wednesday, April 26, 1995 / Notices DIX to the HTSUS—Continued

  • 1344 Cardiovascular Drugs

    1344 Cardiovascular Drugs

  • An Update on Nitrate Tolerance: Can It Be Avoided? S.R.J

    An Update on Nitrate Tolerance: Can It Be Avoided? S.R.J

  • PROVISIONAL PEER REVIEWED TOXICITY VALUES for NITROGLYCERIN (CASRN 55-63-0) Derivation of Subchronic and Chronic Oral Rfds

    PROVISIONAL PEER REVIEWED TOXICITY VALUES for NITROGLYCERIN (CASRN 55-63-0) Derivation of Subchronic and Chronic Oral Rfds

  • Nitric Oxide–Releasing Aspirin Decreases Vascular Injury by Reducing Inflammation and Promoting Apoptosis Jun Yu, Radu Daniel Rudic, and William C

    Nitric Oxide–Releasing Aspirin Decreases Vascular Injury by Reducing Inflammation and Promoting Apoptosis Jun Yu, Radu Daniel Rudic, and William C

  • (12) United States Patent (10) Patent No.: US 9,682,043 B2 Goldman (45) Date of Patent: Jun

    (12) United States Patent (10) Patent No.: US 9,682,043 B2 Goldman (45) Date of Patent: Jun

  • Verquvo; INN Vericiguat

    Verquvo; INN Vericiguat

  • Marrakesh Agreement Establishing the World Trade Organization

    Marrakesh Agreement Establishing the World Trade Organization

Top View
  • Short Communication EFFECTS of MOLSIDOMINE on CORONARY
  • Nitrovasodilators
  • Molsidomine for the Prevention of Vasospasm-Related Delayed
  • Phosphodiesterases in the Liver As Potential Therapeutic Targets of Cirrhotic Portal Hypertension
  • Drug Monograph
  • Drugs Modulating the L-Arginine:NO:Cgmp Pathway – Current Use in Therapy Magdalena Polakowska1, Jolanta Orzelska-Gorka2*, Sylwia Talarek2
  • Specific Aspects of Erectile Dysfunction and Its Treatment for Community Pharmacists
  • The Impact of the Nitric Oxide (NO)/Soluble Guanylyl Cyclase (Sgc) Signaling Cascade on Kidney Health and Disease: a Preclinical Perspective
  • A Practitioner Based Evaluation of Nicorandil on Symptoms and Quality of Life in Patients with Chronic Stable Angina Pectoris
  • Effects of Sildenafil And/Or Muscle Derived Stem Cells on Myocardial
  • (12) Patent Application Publication (10) Pub. No.: US 2017/0072023 A1 ABUCHOWSKI Et Al
  • Therapeutic and Toxic Blood Concentrations of More Than 1100 Drugs and Other Xenobiotics
  • ICD-10-CM TABLE of DRUGS and CHEMICALS 2020
  • SHORT COMMUNICATION Role of NO/Cgmp Signaling Pathway In
  • Vardenafil Preclinical Trial Data: Potency, Pharmacodynamics, Pharmacokinetics, and Adverse Events
  • ICD-10-CM TABLE of DRUGS and CHEMICALS
  • Synergistic Effects on Thromboresistance in Man
  • Increased Guanylate Cyclase Activity Is Associated with an Increase in Cyclic Guanosine 3',5'-Monophosphate in Left Ventricular Hypertrophy


© 2024 Docslib.org    Feedback